Back to Market Feed

Historical record - last NADAC effective date: 12/21/2022

Product Information

INTROVALE 0.15-0.03 MG TABLET is a generic product labeled by Xiromed LLC, priced at $0.1685 per EA under NDC 70700011787. Its NADAC has been published 230 times since Aug 15, 2018.

FDA first approved this application on Sep 27, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

INTROVALE 0.15-0.03 MG TABLET

Levonorgestrel and Ethinyl Estradiol
$0.1685per EA

Manufacturer

Xiromed LLC

NDC

70700011787

Classification

Generic

Dosage Form

KIT

Effective Date

12/21/2022

Approval Type

Generic (ANDA)

FDA Application

ANDA079064

FDA Approved

9/27/2010

TE Code

AB

On Market Since

2/1/2018

Price Statistics

The NADAC for INTROVALE 0.15-0.03 MG TABLET has been published 230 times since Aug 15, 2018, and over the history we have for it it has declined 54.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1685 per EA
All-time high$0.3739 (Aug 14, 2019)
All-time low$0.1685 (Dec 21, 2022)
Median price$0.2728
Average price$0.2675
Largest weekly change+52.6% (May 20, 2020)
Weeks tracked230
Tracking sinceAug 15, 2018

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

-22.2%

All

-54.1%

Last surveyed Jan 4, 2023 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 33%

9 alternatives • Same active ingredient

CHATEAL EQ-28 TABLET
Generic
50102023023•Afaxys Pharma, LLC
$0.1128
Save 33%
AYUNA-28 TABLET
Generic
65862084888•Aurobindo Pharma Limited
$0.1128
Save 33%
MARLISSA-28 TABLET
Generic
68462038829•Glenmark Pharmaceuticals Inc., USA
$0.1128
Save 33%
PORTIA-28 TABLET
Generic
00555902058•Teva Pharmaceuticals USA Inc.
$0.1128
Save 33%
ALTAVERA-28 TABLET
Generic
70700011685•Xiromed LLC
$0.1128
Save 33%
LEVONOR-ETH ESTRAD 0.1-0.02 MG
Generic
00378728753•Mylan Pharmaceuticals Inc.
$0.1509
Save 10%
LEVONOR-ETH ESTRAD 0.1-0.02 MG
Generic
68180085473•Lupin Pharmaceuticals Inc.
$0.1509
Save 10%
SETLAKIN 0.15 MG-0.03 MG TAB
Generic
16714036603•NorthStar Rx LLC
$0.2208
+31% more
TYBLUME 0.1-0.02 MG CHEW TAB
Brand
00642747101•Exeltis USA, Inc.
$0.8275
+391% more

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of INTROVALE 0.15-0.03 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for INTROVALE 0.15-0.03 MG TABLET, manufactured by Xiromed LLC, is $0.1685 per EA (NDC 70700011787), effective Jan 4, 2023.

How has the price of INTROVALE 0.15-0.03 MG TABLET changed over time?

Over the history we have for it, the NADAC for INTROVALE 0.15-0.03 MG TABLET has declined 54.1%. It has been tracked across 230 weekly CMS publications since Aug 15, 2018.

What are the highest and lowest recorded NADAC prices for INTROVALE 0.15-0.03 MG TABLET?

Since Aug 15, 2018, the NADAC for INTROVALE 0.15-0.03 MG TABLET has ranged from a low of $0.1685 (Dec 21, 2022) to a high of $0.3739 (Aug 14, 2019), with a median of $0.2728 per EA.

Are there cheaper alternatives to INTROVALE 0.15-0.03 MG TABLET?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHATEAL EQ-28 TABLET, is $0.1128 per EA — about 33% below INTROVALE 0.15-0.03 MG TABLET.

Who manufactures INTROVALE 0.15-0.03 MG TABLET?

INTROVALE 0.15-0.03 MG TABLET (NDC 70700011787) is labeled by Xiromed LLC, and CMS classifies it as a generic product.